You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GM-CSF secreting myeloma vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Baltimore (biological, drug, other)

Recruiting
  • Multiple Myeloma
  • GM-CSF vaccine
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 6, 2022

Neuroblastoma, Pediatric Solid Tumor Trial in Boston (procedure, biological, drug)

Recruiting
  • Neuroblastoma
  • Pediatric Solid Tumor
  • Tissue collection
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 17, 2022

Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in

Completed
  • Myelodysplastic Syndrome RAEB-I or RAEB-II
  • +2 more
  • GM-CSF secreting leukemia vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 28, 2022

Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

Active, not recruiting
Has Results
  • Renal Cancer
  • Dendritic Cell Tumor Fusion Vaccine
  • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 2, 2023

Neuroblastoma Trial in New York (dietary supplement, drug, biological)

Recruiting
  • Neuroblastoma
  • β-glucan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 5, 2022

Multiple Myeloma Trial in United States (procedure, drug, biological)

Completed
Has Results
  • Multiple Myeloma
  • Tumor Cell Collection
  • +6 more
  • San Francisco, California
  • +14 more
Jul 11, 2022

Platinum Sensitive Ovarian Cancer, Ovarian Cancer Trial in United States (FRa peptide plus Adjuvant (GM-CSF), Adjuvant (GM-CSF)

Terminated
Has Results
  • Platinum Sensitive Ovarian Cancer
  • Ovarian Cancer
  • FRα peptide plus Adjuvant (GM-CSF)
  • Adjuvant (GM-CSF) Alone
  • Birmingham, Alabama
  • +17 more
Nov 21, 2022

Multiple Myeloma Trial in Boston (Nivolumab, DC/myeloma fusions/GM-CSF)

Terminated
Has Results
  • Multiple Myeloma
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 28, 2022

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +11 more
  • Scottsdale, Arizona
  • +11 more
Jan 12, 2023

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

Completed
Has Results
  • Transitional Cell Carcinoma
  • TICE®-strain BCG
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Malignant Melanoma Trial in United States (UV1, GM-CSF)

Active, not recruiting
  • Malignant Melanoma
  • Santa Monica, California
  • +3 more
Nov 16, 2022

Follicular Lymphoma Trial in Boston (Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells)

Active, not recruiting
  • Follicular Lymphoma
  • Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 28, 2022

Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Lymphoma, Mantle Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 4, 2023

Pancreatic Cancer Trial in Baltimore (PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.)

Recruiting
  • Pancreatic Cancer
  • PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022

Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +3 more
Jan 25, 2022

Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

Active, not recruiting
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Incomplete Freund's Adjuvant
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 12, 2022

Advanced Adenocarcinoma, Advanced Malignant Solid Tumor, Metastatic Adenocarcinoma Trial in Sacramento (Antineoplastic Vaccine,

Recruiting
  • Advanced Adenocarcinoma
  • +5 more
  • Antineoplastic Vaccine
  • Sargramostim
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 29, 2021

Breast Ductal Carcinoma In Situ Trial in United States (other, drug, biological, procedure)

Active, not recruiting
  • Breast Ductal Carcinoma In Situ
  • Laboratory Biomarker Analysis
  • +3 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021

Breast Cancer Trial in Durham (ESR1 peptide vaccine)

Recruiting
  • Breast Cancer
  • ESR1 peptide vaccine
  • Durham, North Carolina
    Duke University Medical Center
Sep 13, 2021

Multiple Myeloma Trial in Baltimore (biological, drug, procedure)

Completed
Has Results
  • Multiple Myeloma
  • Activated marrow infiltrating lymphocytes
  • +6 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 16, 2021

Multiple Myeloma Trial in Tampa (biological, procedure, drug)

Active, not recruiting
  • Multiple Myeloma
  • Survivin Vaccine
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 7, 2022